The researchers examined the lifestyle habits, GLP-1 RA usage, and cardiovascular health outcomes of more than 98,000 adults living with T2D and without any prior cardiovascular disease, using data from the Veterans Affairs Million Veteran Program from 2011 to 2023
In the UK, NICE recommends these medications only within specialist weight management services, typically for individuals with specific BMI thresholds and weight-related comorbidities who have not achieved adequate weight loss through diet and exercise alone
View All Specialties Compounded Semaglutide, Tirzepatide, Liraglutide, and other weight management formulations prepared to your provider's prescription
References BECKMAN, K.B
Retatrutide may be of interest to individuals who: Did not tolerate GLP-1 alone Are exploring metabolic flexibility Are interested in appetite and energy expenditure pathways However, retatrutide remains under clinical investigation and is not broadly FDA-approved for obesity at the time of writing
VHE is more frequently observed in patients with congenital defects of the urea enzymatic cycle or with carnitine deficiency [69]
